Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Recruiting · NCT07390123 · Registry updated 2026-05-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Recruiting | Phase 3 | 2026-05-28 | NCT07390123 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Haisco Pharmaceutical Group Co., Ltd. | 50 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Huangshan City People's Hospital | Huangshan City | China | 3 |
| Linyi City People Hospital | Linyi | China | 2 |
| Peking University First Hospital | Beijing | China | 163 |
| Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine | Shanghai | China | 3 |
| The Second Affiliated Hospital of Wannan Medical College | Wuhu | China | 4 |
| The Second Hospital of Jilin University | Changchun | China | 11 |
| Xiangya Hospital of Central South University | Changsha | China | 36 |
| Xijing Hospital | Xi’an | China | 3 |
| Zhanjiang Central Hospital | Zhanjiang | China | 1 |